Filtered By:
Management: Partnerships

This page shows you your search results in order of relevance. This is page number 3.

Order by Relevance | Date

Total 14705 results found since Jan 2013.

Partnerships Between Podiatrists and Vascular Surgeons in Building Effective Wound Care Centers.
Abstract This practice memo, a collaborative effort between the Young Physicians' Program of the American Podiatric Medical Association (APMA) and the Young Surgeons Committee of the Society for Vascular Surgery (SVS), is intended to aid podiatrists and vascular surgeons in the early years of their respective careers, especially those involved in the care of patients with chronic wounds. During these formative years, learning how to successfully establish an inter-professional partnership is crucial in order to provide the best possible care to this important patient population. PMID: 28829154 [PubMed - as supplied by publisher]
Source: Journal of the American Podiatric Medical Association - August 22, 2017 Category: Podiatry Authors: Chandra V, Glebova N, Salvo NL, Wu T Tags: J Am Podiatr Med Assoc Source Type: research

AlloSource touts completion of bioengineered blood vessels for Humacyte trial
Tissue-provider AlloSource said this week it completed production of investigational bioengineered blood vessels designed for Humacyte‘s Phase III clinical trial exploring the use of the vessels to improve vascular access for hemodialysis patients with end-stage renal failure. The trail aims to compare the efficacy of the bioengineered human-tissue vessels to current synthetic vessels made from expanded polytetrafluoroethylene, Centennial, Colo.-based Allosource said. “AlloSource’s partnership with Humacyte supports our focus on regenerative medicine. Our organizations share a deep commitment to developin...
Source: Mass Device - September 14, 2017 Category: Medical Devices Authors: Fink Densford Tags: Research & Development Vascular allosource Humacyte Source Type: news

Corindus partners with Medtronic on interventional cardiology courses, releases prelim Q4, 2017 earnings
Corindus Vascular Robotics (OTC:CVRS) yesterday said it will co-sponsor training courses with medical giant Medtronic (NYSE:MDT) on transradial access techniques and robot-assisted vascular interventions, and released preliminary earnings results for its fourth quarter and fiscal year 2017. The Waltham, Mass.-based company said it plans to help sponsor courses designed to train for operations using robotic-assisted percutaneous coronary interventions using its CorPath GRX system, exploring the benefits of transradial access and devices designed specifically to support those procedures. Corindus said it will partner wit...
Source: Mass Device - January 24, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular MassDevice Earnings Roundup Robotics Wall Street Beat Corindus Vascular Robotics Source Type: news

Mediterranean: MSF's Search and Rescue Ship Aquarius Evacuates 39 Vulnerable People from Boat in Distress
Press releaseMediterranean: MSF's Search and Rescue Ship Aquarius Evacuates 39 Vulnerable People from Boat in DistressApril 01, 2018On the morning of March 31, the search and rescue ship Aquarius —operated in partnership by MSF and SOS MEDITERRANEE—along with the Libyan Coastguard, were alerted by the Italian Rescue Maritime Coordination Centre (IMRCC) to a rubber boat in distress with an estimated 120 people in international waters 23-24 nautical miles from the Libyan coast.
Source: MSF News - April 1, 2018 Category: International Medicine & Public Health Authors: Brienne Prusak Source Type: news

Healthy Baby Boy Born on Aquarius Search and Rescue Ship Two Days After Rescue
Field newsHealthy Baby Boy Born on Aquarius Search and Rescue Ship Two Days After RescueMay 26, 2018On Saturday May 26, a healthy baby boy was born on board the MV Aquarius, a search and rescue ship run in partnership between the international medical humanitarian organisation Doctors Without Borders/M édecins Sans Frontières (MSF) and SOS MEDITERRANEE.The baby, named Miracle, was born in international waters at 3.45 p.m. local time. His mother was rescued just two days before, on Thursday May 24, by an Italian navy vessel and later transferred to the Aquarius.
Source: MSF News - May 27, 2018 Category: International Medicine & Public Health Authors: Jess Brown Source Type: news

John R. (Jack) Hoover, April 22, 1929 to May 22, 2018
John R. “Jack” Hoover was a remarkable man who was in charge of the marketing team for medical products at W. L. Gore beginning in 1975. Over the years, he developed close personal and professional relationships with many of the leading vascular surgeons in the United States and around the world. By lea ding W. L. Gore to support—without asking anything in return —the clinical and research activities of vascular surgeons, he managed to transform the relationship between vascular surgery and industry into one of close partnership.
Source: Journal of Vascular Surgery - September 20, 2018 Category: Surgery Authors: Donald Lass, Peter Gloviczki, Peter F. Lawrence Tags: In memoriam Source Type: research

Impact of educational leadership and interprofessional learning on vascular access training.
This study explores and critically evaluates the impact of educational leadership on practitioner development and clinical practice, focusing specifically on paediatric vascular access. An educational intervention, consisting of theory and practical simulation of venepuncture and cannulation, followed by interprofessional mentorship and supported practice in the clinical setting, was provided to 18 foundation doctors. Data regarding knowledge and skills before and after the intervention, evaluation of expert facilitation and practitioner development was collected through a three-stage process: before and after the training...
Source: British Journal of Nursing - October 18, 2018 Category: Nursing Authors: Hulse A, Cochrane J Tags: Br J Nurs Source Type: research

Vivli to use Cochrane vocabulary to power Vivli ’s search
Cochrane and Vivli formalise partnership aimed at accelerating global medical researchCochrane and Vivli are pleased to announce their partnership aimed at helping health researchers move faster toward new treatments and cures. The first phase of the partnership has been to work together to use the Cochrane ontology to power the Vivli search. Clinical trials included or cited on the Vivli platform are annotated using the Cochrane PICO ontology and vocabulary.  Vivli is a non-profit organization that promotes clinical trial data sharing via a platform designed to serve all elements of the international research community. ...
Source: Cochrane News and Events - October 31, 2018 Category: Information Technology Authors: Katie Abbotts Source Type: news

Ex-Medtronic strategy veep Oesterle joins VC shop New Enterprise Associates | Personnel Moves
Venture capital firm New Enterprise Associates said today it picked up ex-Medtronic (NYSE:MDT) executive veep Dr. Stephen Oesterle as a venture partner for the firm. Prior to being an executive veep for the medical giant, Oesterle served as senior veep of medicine and technology, and served as a member of the executive committee for 14 years, according to NEA. “Dr. Oesterle is one of the most widely known and respected leaders in the medical device industry, and it is an honor to welcome him to the NEA team. Steve brings with him a vast global network of relationships across the academic, technical, clinical, entrep...
Source: Mass Device - September 10, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Allergan Inc. Boston Scientific Ceterix Orthopaedics Cyberonics Inc. Evolent Health iCad Inc. Intronix Iridex Corp. Johnson & Johnson LeMaitre Vascular Inc. LivaNova medtronic New Enterprise Associates P Source Type: news

Corindus wins FDA nod for radial access stenting with CorPath
Corindus Vascular Robotics (OTC:CVRS) said today it won FDA 510(k) clearance for its robotic-assisted CorPath System for use during percutaneous coronary interventions stenting procedures performed via radial access. The approval was based on results from a 30-patient clinical trial of the device that demonstrated a 100% device and clinical success rate, the Waltham, Mass.-based company said. “Radial access is a critical technique to improve patient experience and reduce post procedural complications. It will doubtless become the predominant approach in the U.S. as it has abroad. I routinely use the CorPath System ...
Source: Mass Device - October 6, 2015 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Cardiovascular Catheters Food & Drug Administration (FDA) Regulatory/Compliance Robot-Assisted Surgery Corindus Vascular Robotics Source Type: news

Vascular Access Specialist Training, Experience, and Practice in the United States: Results From the National PICC1 Survey
Vascular access specialists are increasingly responsible for insertion and care of peripherally inserted central catheters in the United States. Despite proliferation of the specialty, little is known about the training, practice patterns, and experiences of these clinicians. In partnership with a vascular access and an infusion nursing organization, a Web-based survey of 1698 clinicians was conducted. Substantial variation in practices related to insertion, use of technology, dressing and flushing, and management of complications was observed. Some reported practices were inconsistent with available evidence-based recomme...
Source: Journal of Infusion Nursing - January 1, 2017 Category: Nursing Tags: Features Source Type: research

Abstract P498: Redox Regulation of Vascular Smooth Muscle cGMP Signaling and Blood Pressure by Cytochrome B5 Reductase 3 Session Title: Vascular
Oxidized soluble guanylate cyclase (sGC) heme iron (Fe3+) is desensitized to nitric oxide (NO) and attenuates cGMP production needed for downstream activation of PKG-dependent signaling and vasodilation. While reactive oxygen species drive oxidation of sGC heme iron, the basic mechanism(s) governing sGC heme iron recycling to its NO-sensitive, reduced state (Fe2+), are unknown. Here we report cytochrome b5 reductase 3 (Cyb5R3), also known as methemoglobin reductase, as a novel sGC heme iron reductase and regulator of cGMP production in vascular smooth muscle cells (VSMCs). Oxidant challenge studies demonstrate that VSMCs h...
Source: Hypertension - September 14, 2017 Category: Cardiology Authors: Adam C Straub, Mizanur Rahaman, Anh Nguyen, Megan Miller, Scott Hahn, Emil Martin Tags: Poster Abstract Presentations Source Type: research

Corindus sees sales rise in Q4, 2017 earnings release
Robotics platform developer Corindus Vascular Robotics (OTC:CVRS) today posted fourth quarter and full year 2017 earnings with sales that topped expectations on Wall Street after seeing a solid day of trading with shares up 21%. The Waltham, Mass.-based company posted losses of approximately $8 million, or 4¢ per share, on sales of $4.2 million for the 3 months ended December 31, seeing losses shrink 18.6% while sales grew a massive 678.8% compared with the same period during the previous fiscal year. Losses per share were just in line with the 4¢ consensus on Wall Street, where analysts expected to see sales of approxi...
Source: Mass Device - March 14, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Corindus Vascular Robotics Source Type: news